Metamizol Heumann

Metamizole, the active ingredient in Metamizol Heumann, is a non‑opioid analgesic presented as an oral formulation for systemic use. It is employed to relieve moderate to severe pain and to reduce fever in adult patients across various clinical settings. It is indicated for postoperative pain, cancer‑related pain, and colic, and is available by prescription only.

GNH USA supplies Metamizol Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements for global distribution.

Metamizole is used to manage pain and fever by acting on the cyclo‑oxygenase pathway.

- Pain: provides analgesic relief for moderate to severe acute or chronic pain. - Fever: reduces elevated body temperature in febrile conditions. - Post‑operative pain: alleviates discomfort following surgical procedures. - Cancer‑related pain: helps control pain associated with malignant disease. - Colic: eases visceral pain such as intestinal or biliary colic.

Metamizole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient sensation of light‑headedness. - Headache: occasional throbbing pain. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Agranulocytosis: severe drop in white blood cells, risk of infection. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before prescribing Metamizole, clinicians should consider several safety factors.

- Renal impairment: monitor kidney function and adjust use as needed. - Hepatic disease: use with caution in patients with liver dysfunction. - History of blood disorders: avoid or closely monitor complete blood counts. - Concomitant NSAIDs: increased risk of gastrointestinal bleeding. - Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. - Store at room temperature: keep in the original container, protect from moisture and light.

Metamizole can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Cytotoxic chemotherapy agents: may amplify bone‑marrow suppression. - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or COX inhibitors: additive gastrointestinal and renal toxicity. - Sulfonamide antibiotics: potential cross‑reactivity leading to hypersensitivity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance hypotensive effects. - Diuretics: monitor blood pressure and electrolyte balance. - Lithium: possible increase in serum lithium levels.